Penicillamine Capsule
Product Images NDC 0591-4171

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Penicillamine (NDC 0591-4171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Penicillamine Capsules 210976 1)

Chemical structure of Penicillamine, depicting its molecular components including methyl groups, a thiol group, an amine group, and a carboxylic acid group.*

FDA Label Image

Process (Penicillamine Capsules 210976 2)

Chemical diagram depicting reactions involving penicillamine and cysteine derivatives, including penicillamine disulfide and penicillamine-cysteine mixed disulfide with respective notation explanations for each chemical species.*

FDA Label Image

Ndc 0591-4171-01 (Penicillamine Capsules 210976 3)

Packaging label for Penicillamine Capsules USP 250 mg by Actavis Pharma, Inc. The label indicates each capsule contains 250 mg of penicillamine, with a package count of 100 capsules. It includes storage instructions, manufacturer details, and warnings, displayed along with the NDC 0591-4171-01 and the TEVA logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.